Tryptophan-kynurenine metabolism: A link between the gut microbiota dysbiosis and cognitive impairment
Microbiological Research · 2026-06 · 307 · 128481
DOI: 10.1016/j.micres.2026.128481 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbiological Research, 2026-06. Verfasst von Qiujin Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, China; Institute of Clinical Pharmacy, Central South Unive…. Hauptthemen laut MEDLINE: Kynurenine, Dysbiosis, Gastrointestinal Microbiome, Tryptophan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 291 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Defense Advanced Research Projects Agency.
Abstract (Originalsprache)
Cognitive impairment is a central feature of neuropsychiatric and neurodegenerative disorders, significantly diminishing patients' quality of life. Emerging evidence underscores the role of gut microbiota dysbiosis in the progression of cognitive decline. The gut microbiota influences brain function through various mechanisms, with the kynurenine pathway standing out as a key biochemical route linking peripheral metabolism to central nervous system function, thereby impacting cognitive performance. Dysregulation of the kynurenine pathway has been closely associated with neurotransmitter imbalances, exacerbated neuroinflammation, and metabolic dysfunction, all of which contribute to the onset and progression of cognitive impairment. Recent studies suggest that interventions targeting the gut microbiota, such as probiotics, antibiotics, and fecal microbiota transplantation, may improve cognitive function by modulating the kynurenine pathway. This review examines the complex relationship between gut microbiota, the kynurenine pathway, and cognition, highlighting the potential of targeting kynurenine pathway-related enzymes and microbiota modulation as therapeutic strategies. Despite promising findings, the precise mechanisms and therapeutic potential of these interventions remain under investigation, offering new avenues for the treatment of cognitive disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, China; Institute of Clinical Pharmacy, Central South University, Changsha, China; International Research Center for Precision Me…
- Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha, China; National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Ho…
Förderung
- National Natural Science Foundation of China
- Defense Advanced Research Projects Agency
Zitieren
APA
Guo, Q., He, Y., Cao, T., Lin, C., Deng, M., Wu, R., & Cai, H. (2026). Tryptophan-kynurenine metabolism: A link between the gut microbiota dysbiosis and cognitive impairment. Microbiological Research, 307, 128481. https://doi.org/10.1016/j.micres.2026.128481
Vancouver
Guo Q, He Y, Cao T, Lin C, Deng M, Wu R, et al. Tryptophan-kynurenine metabolism: A link between the gut microbiota dysbiosis and cognitive impairment. Microbiological Research. 2026;307:128481. doi:10.1016/j.micres.2026.128481
BibTeX
@article{Guo2026,
author = {Guo, Qiujin and He, Yifang and Cao, Ting and Lin, Chenquan and Deng, Minghui and Wu, Renrong and Cai, Hualin},
title = {Tryptophan-kynurenine metabolism: A link between the gut microbiota dysbiosis and cognitive impairment},
journal = {Microbiological Research},
year = {2026},
volume = {307},
pages = {128481},
doi = {10.1016/j.micres.2026.128481}
}
EUVIMED